Kenjarvis Cross, LCSW | |
209 S Lockard St, Blytheville, AR 72315-2541 | |
(870) 763-2139 | |
Not Available |
Full Name | Kenjarvis Cross |
---|---|
Gender | Male |
Speciality | Clinical Social Worker |
Experience | 8 Years |
Location | 209 S Lockard St, Blytheville, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184078875 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arisa Health Inc | 2264853829 | 46 |
News Archive
The famous patient Henry Molaison (long known as H.M.) suffered damage to his hippocampus after a surgical attempt to cure his epilepsy. As a result, he had anterograde amnesia, which meant that things he learned never made it past his short-term memory.
Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
The study, conducted Dr. Kathryn M. Magruder and colleagues, showed that the clinics examined recognized less than half (46.5 percent) the PTSD cases identified by the researchers.
Researchers have discovered the details of how cells repair breaks in both strands of their DNA, a potentially devastating kind of DNA damage.
› Verified 5 days ago
Entity Name | Northeast Arkansas Community Mental Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336118207 PECOS PAC ID: 0244130839 Enrollment ID: O20040110000206 |
News Archive
The famous patient Henry Molaison (long known as H.M.) suffered damage to his hippocampus after a surgical attempt to cure his epilepsy. As a result, he had anterograde amnesia, which meant that things he learned never made it past his short-term memory.
Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
The study, conducted Dr. Kathryn M. Magruder and colleagues, showed that the clinics examined recognized less than half (46.5 percent) the PTSD cases identified by the researchers.
Researchers have discovered the details of how cells repair breaks in both strands of their DNA, a potentially devastating kind of DNA damage.
› Verified 5 days ago
Entity Name | Arisa Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437750411 PECOS PAC ID: 2264853829 Enrollment ID: O20230508000555 |
News Archive
The famous patient Henry Molaison (long known as H.M.) suffered damage to his hippocampus after a surgical attempt to cure his epilepsy. As a result, he had anterograde amnesia, which meant that things he learned never made it past his short-term memory.
Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
The study, conducted Dr. Kathryn M. Magruder and colleagues, showed that the clinics examined recognized less than half (46.5 percent) the PTSD cases identified by the researchers.
Researchers have discovered the details of how cells repair breaks in both strands of their DNA, a potentially devastating kind of DNA damage.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kenjarvis Cross, LCSW 209 S Lockard St, Blytheville, AR 72315-2541 Ph: (870) 763-2139 | Kenjarvis Cross, LCSW 209 S Lockard St, Blytheville, AR 72315-2541 Ph: (870) 763-2139 |
News Archive
The famous patient Henry Molaison (long known as H.M.) suffered damage to his hippocampus after a surgical attempt to cure his epilepsy. As a result, he had anterograde amnesia, which meant that things he learned never made it past his short-term memory.
Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
The study, conducted Dr. Kathryn M. Magruder and colleagues, showed that the clinics examined recognized less than half (46.5 percent) the PTSD cases identified by the researchers.
Researchers have discovered the details of how cells repair breaks in both strands of their DNA, a potentially devastating kind of DNA damage.
› Verified 5 days ago